INDV · earnings call history
Indivior Pharmaceuticals Q1 FY26 — Strong SUBLOCADE Growth Drives Raised Full-Year Guidance
Read the briefIndivior Q4 FY25 — SUBLOCADE Momentum and Strong 2026 Outlook
Read the briefBrowse all US companies on the earnings-call register.